MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.

Oncotarget · 2016 · PMC5122342 · PMID 27177222

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantP = 0.000not a probability at all

The positive correlation between DNMT1 and Survivin was highly significant in both tumors ( r = 0.919, P = 0.000) and normal tissues ( r = 0.983, P = 0.000) (Figure 10E ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.